Table 2 EORTC QLQ-C30 characteristics of 2871 prostate cancer patients treated with robot-assisted radical prostatectomy at the Prostate Cancer Center Northwest, Gronau, Germany between 2006 and 2018 stratified according to the CAPRA-S risk group and fulfillment the pentafecta criteria.

From: Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S)

Value

All patients (n = 2871)

CAPRA-S low risk group (n = 1514)

CAPRA-S intermediate risk group (n = 925)

CAPRA-S high risk group (n = 432)

p-value

Pentafecta group (n = 1469)

Nonpentafecta group (n = 1402)

p-value

Preoperative Global Quality of Life (QL), mean (SD)

75.4

19.2

75.7

19.4

75.1

18.9

75.2

19.4

0.7a

75.6

19.7

75.2

18.7

0.6

Preoperative EORTC QLQ-C30 Summary Score, mean (SD)

91.0

9.1

91.0

9.2

90.9

8.9

91.2

9.2

0.8a

91.3

9.0

90.7

9.3

0.08

Global Quality of Life (QL) at 24 months after surgery, mean (SD)

77.5

19.5

79.3

19.3

76.5

19.1

73.7

20.7

< 0.001a

80.8

18.3

74.1

20.2

< 0.001

EORTC QLQ-C30 Summary Score at 24 months after surgery, mean (SD)

89.3

11.9

90.2

11.5

88.8

11.6

87.6

13.4

< 0.001a

91.2

10.3

87.4

13.1

< 0.001

Global Quality of Life (QL) change at 24 months after surgery, n (%)

Major improvement

378

13%

207

14%

115

12%

56

13%

< 0.001a

224

15%

154

11%

< 0.001

Moderate improvement

441

15%

259

17%

130

14%

52

12%

 

257

17%

184

13%

 

Minor improvement

342

12%

199

13%

112

12%

31

7.2%

 

206

14%

136

10%

 

Stable

834

29%

451

30%

271

29%

112

26%

 

442

30%

392

28%

 

Minor deterioration

274

10%

126

8.3%

94

10%

54

13%

 

111

7.6%

163

12%

 

Moderate deterioration

327

11%

147

10%

114

12%

66

15%

 

140

10%

187

13%

 

Major deterioration

275

10%

125

8.3%

89

10%

61

14%

 

89

6.1%

186

13%

 

EORTC QLQ-C30 Summary Score change at 24 months after surgery, n (%)

Major improvement

41

1.4%

22

1.5%

10

1.1%

9

2.1%

< 0.001a

25

1.7%

16

1.1%

< 0.001

Moderate improvement

167

5.8%

98

6.5%

47

5.1%

22

5.1%

 

93

6.3%

74

5.3%

 

Minor improvement

307

11%

193

13%

82

8.9%

32

7.4%

 

181

12%

126

9.0%

 

Stable

1579

55%

848

56%

510

55%

221

51%

 

877

60%

702

50%

 

Minor deterioration

350

12%

163

11%

127

14%

60

14%

 

140

10%

210

15%

 

Moderate deterioration

293

10%

136

9.0%

103

11%

54

13%

 

112

7.6%

181

13%

 

Major deterioration

134

4.7%

54

3.6%

46

5.0%

34

7.9%

 

41

2.8%

93

6.6%

 
  1. Significant values are in italics.
  2. CAPRA-S the postsurgical Cancer of the Prostate Risk Assessment score, EORTC QLQ-C30 European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, SD standard deviation, QoL quality of life.
  3. aCAPRA-S low risk vs. CAPRA-S high risk.
Back to article page